First-in-Human vaccine trial targets deadly brain cancer
Disease control
Not yet recruiting
This early-phase trial tests a new personalized vaccine (Bvax) added to standard chemoradiotherapy for people with newly diagnosed glioblastoma, an aggressive brain cancer. The study aims to see if the vaccine is safe and feasible, and whether it can help control the disease. Abo…
Phase: PHASE1 • Sponsor: Catalina Lee Chang • Aim: Disease control
Last updated May 17, 2026 10:28 UTC